Author Question: A patient diagnosed with depression has been taking a selective serotonin-reuptake inhibitor (SSRI) ... (Read 22 times)

faduma

  • Hero Member
  • *****
  • Posts: 528
A patient diagnosed with depression has been taking a selective serotonin-reuptake inhibitor (SSRI) throughout her pregnancy. What neonatal consequences are possible?
 
  1. Malformations
  2. High birth weight
  3. Neural tube defects
  4. Poorer neurobehavioral adaptation

Question 2

A patient with bipolar disorder has unexpectedly become pregnant and is concerned about the possible impact of valproate on her and her baby. What can the nurse tell her?
 
  1. Valproate is not associated with any fetal risks.
  2. There is no problem if you stop your medications.
  3. Valproate has been associated with several significant fetal risks.
  4. If you take other medications, you can reduce the risks of valproate.



LegendaryAnswers

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

Answer: 4
Explanation: Poorer neurobehavioral adaptation (PNA), similar to the discontinuation symptoms of SSRIs, has been shown in neonates whose mothers were taking SSRIs. There is no association between malformations and SSRI use in pregnancy. Low birth weight may be an adverse outcome of maternal SSRI use. Neural tube defects have been associated with certain mood stabilizers.

Answer to Question 2

Answer: 3
Explanation: Both sodium valproate and carbamazepine have been associated with an increased risk of neural tube defects and fetal anticonvulsant syndromes. Valproate is associated with multiple fetal risks. There is a significant risk of a bipolar relapse if the patient stops taking her medications suddenly. Increased teratogenic risk is actually compounded by polypharmacy.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

For a complete list of videos, visit our video library